Les meilleurs doctors à Ramat Gan pour votre TEP/TDM - TOP 10 des médecins

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Neurosurgeon | Director of Neurosurgery Department | Neuro-Oncology Expert

Included in Forbes Israel’s “Best Doctors” List (2025)

Areas of Expertise

Professor Zvi Cohen specializes in advanced neurosurgery and neuro-oncology, focusing on both benign and malignant tumors of the central nervous system:

Malignant Brain Tumors

Comprehensive surgical and multidisciplinary treatment

Benign Brain Tumors

Precision microsurgical and minimally invasive approaches

Pituitary Adenomas

Advanced surgical management using modern techniques

Spinal and Spinal Cord Tumors

Surgical treatment of primary and metastatic lesions

Brain Metastases

Image-guided tumor resection and radiosurgical strategies

Neurosurgery

Full spectrum of complex cranial and spinal procedures

About the Doctor

Professor Zvi Cohen is a leading neurosurgeon and neuro-oncology specialist, serving as the Director of the Neurosurgery Department at Sheba Medical Center.

He also leads clinical research initiatives within the department, focusing on evaluating the effectiveness of modern pharmacological therapies for malignant brain tumors.

Prof. Cohen has extensive experience in performing complex neurosurgical procedures, including surgeries for tumors of the brain, spine, and spinal cord.

His surgical expertise includes:

frame-based and frameless stereotactic brain biopsies

image-guided tumor resection

use of intraoperative MRI for maximum precision and safety

He is also the founder of the brain tumor tissue bank at Sheba Medical Center, contributing to ongoing advancements in neuro-oncology research.

Clinical Approach

Professor Cohen applies a highly precise, technology-driven, and multidisciplinary approach, combining surgery with advanced imaging and oncology expertise.

His priorities include:

maximal tumor removal with functional preservation

minimizing neurological deficits

use of cutting-edge technologies (intraoperative MRI, navigation systems)

integration of surgery with systemic and targeted therapies

Positions

Director, Department of Neurosurgery, Sheba Medical Center

Director, Neuro-Oncology Unit

Deputy Director, Department of Neurosurgery

Assistant Professor of Neurosurgery, Tel Aviv University

Education and Training

MD, School of Medicine, Tel Aviv University, Israel

Residency in Neurosurgery, Sheba Medical Center

Fellowship in Neuroradiology, Beth Israel Medical Center, USA

Fellowship in Neurosurgical Oncology, MD Anderson Cancer Center, Houston, USA

Board Certifications

Neurosurgery

Professional Memberships

Member of Society for Neuro-Oncology

Member of Israeli Association of Neurological Surgeons

Research & Publications

Professor Cohen is actively involved in clinical and translational research in neuro-oncology and has contributed to multiple scientific publications, including:

The impact of intraoperative neurophysiological monitoring on outcomes in spinal tumors

Radiosurgery approaches for brain metastases and associated cerebral edema

His work supports continuous improvement in surgical precision and patient outcomes in complex neurosurgical oncology

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Jair Bar, MD, PhD, Professor

Thoracic Oncologist | Deputy Director of Cancer Center | Lung Cancer Specialist

Areas of Expertise

Professor Jair Bar specializes in thoracic oncology, with a strong focus on advanced lung cancer treatment and translational research:

Lung Cancer (non-small cell and advanced stages)

Thoracic Oncology

Medical Oncology & Radiotherapy

Molecular Biology & Genetics in Cancer

Immunotherapy and Resistance Mechanisms

Translational Oncology Research

About the Doctor

Professor Jair Bar is a leading thoracic oncologist and serves as the Deputy Director of the Cancer Center at Sheba Medical Center.

He also heads the Thoracic Oncology Unit, where he focuses on the treatment of lung cancer using advanced systemic therapies, including immunotherapy and targeted treatments.

In addition to his clinical work, Prof. Bar leads a research laboratory dedicated to studying resistance to immunotherapy, contributing to the development of more effective cancer treatment strategies.

He combines clinical expertise with cutting-edge research, ensuring that patients benefit from the most up-to-date therapeutic approaches.

Clinical Approach

Personalized cancer treatment based on molecular and genetic profiling

Integration of immunotherapy, targeted therapy, and radiotherapy

Multidisciplinary decision-making for complex cases

Focus on improving survival outcomes and quality of life

Positions

Deputy Director, Cancer Center, Sheba Medical Center

Head of Thoracic Oncology Unit

Chair, Israel Lung Cancer Group (since 2003)

Senior Lecturer, Tel Aviv University

Professional Memberships

Member of Israel Society of Clinical Oncology and Radiotherapy

Member of American Society of Clinical Oncology

Member of American Association for Cancer Research

Education and Training

MD, Hebrew University of Jerusalem (Hadassah Medical School)

PhD in Molecular Biology, Weizmann Institute of Science

Board Certifications

Medical Oncology

Radiotherapy Oncology

Research & Publications

Professor Bar is actively involved in translational and clinical research, with publications focused on lung cancer biology and treatment, including:

Cancer metabolism in lung cancer based on exhaled breath analysis

Angiogenesis inhibition strategies in lung cancer therapy

He continues to contribute to advancing precision oncology and immunotherapy approaches in thoracic cancers.